NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Does anyone actually review 1.7 million pages, I think not. I certainly don't know, but I would guess that under 1000 pages are deemed to be critical and subjected to such critical review.

To me, the problem with the regulators is that they demand such a document, and of course, the industry complies. If they want to cut the costs of drug development, just reduce the filing to not more than 1000 pages.

Gary